Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03458026
Other study ID # 17-PP-12
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 23, 2018
Last updated March 8, 2018
Start date March 2018
Est. completion date March 2022

Study information

Verified date February 2018
Source Centre Hospitalier Universitaire de Nice
Contact Christian ROUX, Pr
Phone 04 92 03 54 91
Email roux.c2@chu-nice.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

By this project, the investigators are going to try to demonstrate that to use objects connected to make a physical activity can have an impact on the clinical activity of the disease by bringing the subjects which present a spondyloarthritis to make a physical activity. The investigators shall show furthermore, than the use of connected objects also has better chances to glue the patients presenting a spondyloarthritis to a practice of regular physical activity that a simple recommendation.


Description:

This project is aimed at subjects with Axial Spondyloarthritis and / or peripheral of the Alpes Maritimes and more specifically of the city of Nice and its surroundings. The subjects will be recruited by the hospital doctors (consultations, hospitalization). Patients will benefit from an inclusion visit in order to explain the protocol, sign the study consent and eliminate a possible contraindication to physical activity. Knowing that this is a physical activity adapted to the health of people and their physical abilities.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 140
Est. completion date March 2022
Est. primary completion date March 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Presenting a spondyloarthritis according to the criteria of the ASAS (l'Assessment of SpondyloArthritis international Society)

- Benefiting from a stable treatment by biotherapies for at least 3 months

Exclusion Criteria:

- Patient presenting a cardiac pathology should be decompensating

- Patients having a contraindication in the physical activity

- Lung affection making impossible the effort

- Patient already realizing a physical activity supervised in club or with sports coach

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Connected object use combined with SMS (text messages) of physical activity reminders
Watch connected used and receipt of SMS (text messages)
Without connected object
Any intervention except follow-up visit

Locations

Country Name City State
France CHU de Nice Nice

Sponsors (3)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice Azur sante, LAMHNESS

Country where clinical trial is conducted

France, 

References & Publications (4)

Fongen C, Sveaas SH, Dagfinrud H. Barriers and Facilitators for Being Physically Active in Patients with Ankylosing Spondylitis: A Cross-sectional Comparative Study. Musculoskeletal Care. 2015 Jun;13(2):76-83. doi: 10.1002/msc.1088. Epub 2014 Nov 5. — View Citation

O'Dwyer T, McGowan E, O'Shea F, Wilson F. Physical Activity and Exercise: Perspectives of Adults With Ankylosing Spondylitis. J Phys Act Health. 2016 May;13(5):504-13. doi: 10.1123/jpah.2015-0435. Epub 2015 Oct 28. — View Citation

Passalent LA, Soever LJ, O'Shea FD, Inman RD. Exercise in ankylosing spondylitis: discrepancies between recommendations and reality. J Rheumatol. 2010 Apr;37(4):835-41. doi: 10.3899/jrheum.090655. Epub 2010 Mar 1. — View Citation

Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J. Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis. 2005 Oct;64(10):1431-5. Epub 2005 Apr 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of pushes brought reported by the patient through a filled auto-questionnaire every week This questionnaire containing 3 items: did you present a push of your disease since the last filling of the questionnaire?,not, yes during 1 in 3 in the daytime,yes more than 3 days After 12 weeks
Secondary Moderators of the membership will be estimated thanks to the EMAPS (Scale of Motivation for Physical activity for health purposes) and thanks to the Big five the EMAPS questionnaire will allow to quantify by the motivation of the patients to practice a physical activity.
this questionnaire is specifically for health purposes.
12 weeks
Secondary The level of commitment in the physical activity will be estimated by the questionnaire GPAQ (Global Physical Activity Questionnaire) the qestionnaire GPAQ is a scale to quantify overall physical activity (based on physical activity at work and in the home). 12 weeks
Secondary The function will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index) 12 weeks
Secondary The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) 12 weeks
Secondary The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index) 12 weeks
Secondary The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire) the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis. 12 weeks
Secondary The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) 24 weeks
Secondary The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index) 24 weeks
Secondary The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire) the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis. 24 weeks
Secondary The activity of the disease will be estimated by the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) 36 weeks
Secondary The activity of the disease will be estimated by the BASFI (Bath Ankylosing Spondylitis Fonctional Index) 36 weeks
Secondary The activity of the disease will be estimated by the ASQOL (Ankylosing Spondylitis Quality of Life Questionnaire) the ASQOL questionnaire is a quality of life scale. this questionnaire is specifically designed for patients with spondyloarthritis. 36 weeks
See also
  Status Clinical Trial Phase
Completed NCT03564743 - Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
Completed NCT01219257 - Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
Recruiting NCT05433168 - Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis N/A
Terminated NCT03232580 - 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis Phase 2
Recruiting NCT05039216 - Biobank for Inflammatory Chronic Diseases and Osteoporosis
Completed NCT04483648 - Cervical Stabilization Exercises in Patients With Spondyloarthritis N/A
Recruiting NCT04602091 - Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Not yet recruiting NCT04077957 - Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs Phase 4
Recruiting NCT05290363 - The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis N/A
Not yet recruiting NCT05006690 - Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis N/A
Completed NCT02998398 - Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
Completed NCT02148640 - The NOR-SWITCH Study Phase 4
Completed NCT01174186 - Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Phase 4
Recruiting NCT04499001 - Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
Completed NCT03253796 - Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Phase 4
Active, not recruiting NCT04169373 - A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis Phase 3
Recruiting NCT04292067 - Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Completed NCT04946539 - Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
Recruiting NCT03983473 - Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. N/A
Terminated NCT03345355 - MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis